Zoetis Inc ZTS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:57 PM EDT
151.35UNCH (UNCH)
Volume
65,581
Close
151.35quote price arrow up+3.06 (+2.06%)
Volume
1,494,784
52 week range
147.77 - 249.27
Loading...
  • Open149.28
  • Day High152.85
  • Day Low148.31
  • Prev Close148.29
  • 52 Week High249.27
  • 52 Week High Date12/30/21
  • 52 Week Low147.77
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap70.853B
  • Shares Out468.14M
  • 10 Day Average Volume1.84M
  • Dividend1.30
  • Dividend Yield0.86%
  • Beta0.76
  • YTD % Change-37.98

KEY STATS

  • Open149.28
  • Day High152.85
  • Day Low148.31
  • Prev Close148.29
  • 52 Week High249.27
  • 52 Week High Date12/30/21
  • 52 Week Low147.77
  • 52 Week Low Date09/27/22
  • Market Cap70.853B
  • Shares Out468.14M
  • 10 Day Average Volume1.84M
  • Dividend1.30
  • Dividend Yield0.86%
  • Beta0.76
  • YTD % Change-37.98

RATIOS/PROFITABILITY

  • EPS (TTM)4.41
  • P/E (TTM)34.35
  • Fwd P/E (NTM)28.76
  • EBITDA (TTM)3.321B
  • ROE (TTM)46.81%
  • Revenue (TTM)7.995B
  • Gross Margin (TTM)70.44%
  • Net Margin (TTM)26.12%
  • Debt To Equity (MRQ)143.52%

EVENTS

  • Earnings Date11/03/2022
  • Ex Div Date07/20/2022
  • Div Amount0.325
  • Split Date-
  • Split Factor-

Latest On Zoetis Inc

Content From Our Affiliates

Related Video

Pro Picks: Watch all of Wednesday's big stock calls on CNBC
VIDEO6:3906:39
Pro Picks: Watch all of Wednesday's big stock calls on CNBC

Profile

MORE
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines...
Michael Mccallister
Non-Executive Independent Chairman of the Board
Kristin Peck
Chief Executive Officer, Director
Wetteny Joseph
Chief Financial Officer, Executive Vice President
Jeannette Ferran Astorga
Executive Vice President - Corporate Affairs, Communications, Chief Sustainability Officer
Robert Polzer Ph.D.
Executive Vice President, President - Research and Development
Address
10 Sylvan Way
Parsippany, NJ
07054
United States

Top Peers

SYMBOLLASTCHG%CHG
VRTX
Vertex Pharmaceuticals Inc
297.43+7.89+2.73%
TAK
Takeda Pharmaceutical Co Ltd
13.05+0.08+0.62%
GILD
Gilead Sciences Inc
62.32+0.63+1.02%
SGEN
Seagen Inc
137.70+0.87+0.64%
CTLT
Catalent Inc
76.52+4.16+5.75%